Iceland - Antiarrhythmic Medicine Use
Since 2014, Iceland Antiarrhythmic Medicine Use rose 2.4% year on year. At 4.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 11 among other countries in Antiarrhythmic Medicine Use. Iceland is overtaken by Portugal, which was ranked number 10 with 4.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Slovenia at 3.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Slovakia lead the ranking with 10.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.9% versus 2018. Czech Republic, Belgium and Italy respectively ranked number 2, 3 and 4 in this ranking. South Korea recorded the best 5 years average growth at +7% per year, while Chile witnessed the worst performance at -4.1% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 4.50 |
| 2018 | 4.50 |
| 2017 | 4.30 |
| 2016 | 4.30 |
| 2015 | 4.20 |
How does Iceland rank in Antiarrhythmic Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Slovakia
|
11 | 2019 | +3.9 % | +1.4 % | View data | |
| 2 |
#2
Czech Republic
|
9 | 2019 | +2.3 % | +1.9 % | View data | |
| 10 |
#10
Portugal
|
5 | 2019 | -6.0 % | -4.1 % | View data | |
| 11 |
#11
Iceland
|
5 | 2019 | +0.0 % | +2.4 % | View data | |
| 12 |
#12
Slovenia
|
4 | 2019 | -2.5 % | -1.5 % | View data | |